Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications

Annals of Medicine

Volumn 37, Issue 8, 2005, Pages 613-620

  Čolak, Emina ^a   Majkić Singh, Nada ^a   Stanković, Sanja ^a   Srecković Dimitrijević, Vesna ^a   Djordjević, Predrag B ^a   Lalić, Katarina ^a   Lalić, Nebojša ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Antioxidative defense; Cardiovascular complications; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 28844435981     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890500330193     Document Type: Article

References (30)

1. Laakso M. Hyperglycaemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937-42.
2. Aronson D, Rayfield EJ. How hyperglycaemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002;1:1.
3. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-90.
4. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 2000;14:439-47.
5. Park JY, Takohara N, Gabriele A, Chon E, Naruse K, Suzuma K, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000;49:1239-48.
6. Nabel E, Shum L, Pompili V, Yang ZY, Sau H, Shu HB, et al. Direct transfer of transforming growth factor b1 gene into arteries stimulates fibro cellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90:10759-63.
7. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-478.
8. Touyz RM. Reactive oxygen species, vascular oxidative stress and redox signalling in hypertension: what is the clinical significance? Hypertension. 2004;44:248-52.
9. Wolf SP. Diabetes mellitus and free radicals. Free radicals transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull. 1993;49:642-52.
10. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new prospective on an old paradigm. Diabetes. 1999;48:1-9.
11. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia. 1995;38:201-10.
12. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes care. 1998;21:1736-42.
13. Chen MS, Hutchinson ML, Pecoraro RE, Lee WY, Labbe RF. Hyperglycaemia- induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes. 1983;32:1078-81.
14. Yue DK, McLennan S, Fisher E, Heffernan S, Capogreco C, Ross GR, et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes. 1989;38:257-261.
15. Korac B, Buzadzic B. Oxidative stress and antioxidative protection in the skin. Jugoslov Med Biohem. 2000;19:363-79.
16. Korać B, Buzadzić B. Oxidative stress and antioxidative defence in the skin of rats with thermal injury. Jugosl Med Biochem. 2003;22:33-9.
17. Goldstein S, Michel C, Boors A, Saran M, Czapski G. A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Radical Biol Med. 1988;4:295-303.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of glutathione peroxidase. J Lab Clin Med. 1967;70:158-63.
19. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993;84:407-12.
20. Goldberg DM, Spooner RJ. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 3rd ed. New York: Academic Press; 1974, Vol 3, p. 258-65.
21. Čolak E, Stanković S, Majkić-Singh N, Lalić K, Lalić N, Srećković-Dimitrijević V, et al. The effect of hyperglycemia on the values of antioxidative parameters in non- insulin dependent diabetics with cardiovascular complications. Proceedings of the 15th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine: 2003 June 1-5; Barcelona, Spain; Monduzzi Editore, Euromedlab. 291-4.
22. Dimitrijević-Srećković S.V, Djordjević B.P, Popović S.S, Gostiljac D, Canović F, Srećković MB, et al. Metabolic syndrome and antioxidative activity in early glycoregulation disorders. Diabetologia. 2004;47(Suppl 1): A 143 (Abstract book of the 40th Annual Meeting of the EASD, Munich, Germany, 5-9 September 2004).
23. Oda A, Bannai C, Yamaoka T, Katori T, Matsushima T, Yamashita K. Inactivation of Cu, Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm Metab Res. 1994;26:1-4.
24. Kotake M, Shinohara R, Kato K, Hayakawa N, Hayashi R, Uchimura K, et al. Reduction of activity but not decrease in concentration of erythrocyte Cu,Zn- superoxide dismutase by hyperglycaemia in diabetes patients. Diabet Med. 1998;15:668-71.
25. Yücel D, Aydosdu S, Cehreli S, Saydam G, Canatan H, Senes M, et al. Increased oxidative stress in dilated cardiomyopatic heart failure. Clin Chem. 1998;44:148-54.
26. Ndahimana J, Dorchy H, Vertongen F. Erythrocyte and plasma antioxidant activity in diabetes mellitus type 1. Press Med. 1996;25:188-92.
27. Valabhji J, McCool AJ, Richmond W, Shatter M, Rubens MB, Elkeles RS. Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care. 2001;24:1608-13.
28. Ročić B, Vučić M, Knežević-Cuca J, Radica A, Pavlić-Renar I, Prozofić V, et al. Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes. Exp Clin Endocrinol Diabetes. 1997;105:213-7.
29. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-12.
30. Marković S, Djordjević J, Majkić-Singh N, Vasiljević Z, Petrović M, Glavinić L, et al. The importance of antioxidant enzymes and total antioxidant status of patients with acute myocardial infarction on thrombolytic therapy. Clin Lab. 2000;46:495-9.